Regulations.gov document
Eli Lilly & Co. and Bristol-Myers Squibb Co.; Withdrawal of Approval of Three New Drug…
Notice · FDA-1976-N-0520 · posted Nov 4, 1998
Key facts
| Document ID | FDA-1976-N-0520-0011 |
|---|---|
| Title | Eli Lilly & Co. and Bristol-Myers Squibb Co.; Withdrawal of Approval of Three New Drug Applications for Estrogen-Androgen Combination Drugs |
| Document type | Notice |
| Subtype | NWL-Notice of Withdrawl |
| Agency | FDA |
| Docket | FDA-1976-N-0520 |
| Posted | Nov 4, 1998 |
At a glance
- 1–9 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: